Founded in 2004, Pharmaron has invested in its people and facilities and established a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. This is an opportunity to take ownership of complex small-molecule programs across the development lifecycle-from early-phase development and clinical supply through technology transfer, GMP manufacturing, process validation, and commercial production.